Sen. Baldwin Renews Call for HHS I.G. Investigation Into Trump Administration's Promotion of Hydroxychloroquine
May 15, 2020
May 15, 2020
WASHINGTON, May 15 -- Sen. Tammy Baldwin, D-Wisconsin, issued the following news release:
U.S. Senator Tammy Baldwin renewed her call for the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) to investigate the Trump administration's promotion of hydroxychloroquine as a treatment for COVID-19, despite the fact that it is not a Food and Drug Administration (FDA) approved treatment for the coronavirus.
On April 28, Senator Baldwin fi . . .
U.S. Senator Tammy Baldwin renewed her call for the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) to investigate the Trump administration's promotion of hydroxychloroquine as a treatment for COVID-19, despite the fact that it is not a Food and Drug Administration (FDA) approved treatment for the coronavirus.
On April 28, Senator Baldwin fi . . .